[DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis*; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy; D008214:Lymphocytes / Q000378:metabolism*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000097:blood* / Q000188:drug therapy
D006046:Gold; D002738:Chloroquine; D004247:DNA; D010396:Penicillamine; D001379:Azathioprine; D008775:Methylprednisolone; D007213:Indomethacin; D008727:Methotrexate
DNS-synthetisierende Blutlymphozyten bei Patienten mit Lupus erythematodes disseminatus, primär chronischer Polyarthritis und Panarteriitis nodosa